What Researchers Did
Researchers in Portugal looked back at the records of 58 people with a rare, severe soft tissue infection who were treated with hyperbaric oxygen (HBO2) therapy, to see how surgery, HBO2 and negative pressure wound therapy related to the time it took to get the infection under control.
What They Found
In this retrospective study of 58 patients with necrotizing soft tissue infections treated with HBO2, a statistical model linked more frequent and earlier HBO2 sessions to a shorter time until source control (control of the infection's origin). Overall mortality was 13.8 percent, and the mean time until source control was 10.4 days. Patients averaged 0.62 surgical interventions and 1.06 HBO2 sessions per day. After adjusting for other factors, doubling the number of HBO2 sessions per day was associated with source control about five days sooner. Each day HBO2 was delayed was associated with source control one day later.
What This Means for Canadian Patients
For people with necrotizing soft tissue infections, this study suggests that how early and how often HBO2 sessions were given was linked to how quickly the infection was controlled in this group. It was not a trial that assigned treatments, so it cannot show that HBO2 caused the faster control. The abstract also reports that about 1 in 7 patients died, which shows how serious these infections are. Treatment decisions belong with the surgical and hyperbaric medicine team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective study from a single hyperbaric unit with 58 patients and no comparison group of patients who did not receive HBO2, so the links it found may not reflect cause and effect.